These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10850638)

  • 1. Effects of phytate and pyrophosphate on brushite and hydroxyapatite crystallization. Comparison with the action of other polyphosphates.
    Grases F; Ramis M; Costa-Bauzá A
    Urol Res; 2000 Apr; 28(2):136-40. PubMed ID: 10850638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism between the brushite and hydroxyapatite urinary crystallization inhibitors.
    Costa-Bauzá A; Barceló C; Perelló J; Grases F
    Int Urol Nephrol; 2002; 34(4):447-51. PubMed ID: 14577482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development.
    Costa-Bauzá A; Isern B; Perelló J; Sanchis P; Grases F
    Scand J Urol Nephrol; 2005; 39(3):194-9. PubMed ID: 16118089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.
    Costa-Bauzá A; Perelló J; Isern B; Sanchis P; Grases F
    BMC Urol; 2006 Jul; 6():16. PubMed ID: 16822299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Phytate (InsP6) and Other Inositol-Phosphates (InsP5, InsP4, InsP3, InsP2) on Crystallization of Calcium Oxalate, Brushite, and Hydroxyapatite.
    Calvó P; Costa-Bauza A; Grases F
    Biomolecules; 2023 Jun; 13(7):. PubMed ID: 37509097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phytate (IP6) is a powerful agent for preventing calcifications in biological fluids: usefulness in renal lithiasis treatment.
    Grases F; Costa-Bauzá A
    Anticancer Res; 1999; 19(5A):3717-22. PubMed ID: 10625946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of phytate on crystallization on ureteral stents and bacterial attachment: an in vitro study.
    Calvó P; Mateu-Borras M; Costa-Bauza A; Albertí S; Grases F
    Urolithiasis; 2022 Dec; 50(6):737-742. PubMed ID: 36064981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytate acts as an inhibitor in formation of renal calculi.
    Grases F; Isern B; Sanchis P; Perello J; Torres JJ; Costa-Bauza A
    Front Biosci; 2007 Jan; 12():2580-7. PubMed ID: 17127264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticalculus effect of a triclosan mouthwash containing phytate: a double-blind, randomized, three-period crossover trial.
    Grases F; Perelló J; Sanchis P; Isern B; Prieto RM; Costa-Bauzá A; Santiago C; Ferragut ML; Frontera G
    J Periodontal Res; 2009 Oct; 44(5):616-21. PubMed ID: 18973518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Mixtures of Magnesium, Citrate and Phytate as Calcium Oxalate Crystallization Inhibitors in Urine.
    Grases F; Rodriguez A; Costa-Bauza A
    J Urol; 2015 Sep; 194(3):812-9. PubMed ID: 25818031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary phytate in calcium oxalate stone formers and healthy people--dietary effects on phytate excretion.
    Grases F; March JG; Prieto RM; Simonet BM; Costa-Bauzá A; García-Raja A; Conte A
    Scand J Urol Nephrol; 2000 Jun; 34(3):162-4. PubMed ID: 10961468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual roles of brushite crystals in calcium oxalate crystallization provide physicochemical mechanisms underlying renal stone formation.
    Tang R; Nancollas GH; Giocondi JL; Hoyer JR; Orme CA
    Kidney Int; 2006 Jul; 70(1):71-8. PubMed ID: 16641926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of seed crystals of hydroxyapatite and brushite on the crystallization of calcium oxalate in undiluted human urine in vitro: implications for urinary stone pathogenesis.
    Grover PK; Kim DS; Ryall RL
    Mol Med; 2002 Apr; 8(4):200-9. PubMed ID: 12149569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytate inhibits bovine pericardium calcification in vitro.
    Grases F; Sanchis P; Costa-Bauzá A; Bonnin O; Isern B; Perelló J; Prieto RM
    Cardiovasc Pathol; 2008; 17(3):139-45. PubMed ID: 18402805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal lithiasis and nutrition.
    Grases F; Costa-Bauza A; Prieto RM
    Nutr J; 2006 Sep; 5():23. PubMed ID: 16956397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental model to study sedimentary kidney stones.
    Grases F; Llobera A
    Micron; 1998; 29(2-3):105-11. PubMed ID: 9684348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of oxalocalcic lithiasis: effects of their interactions on calcium oxalate crystallization.
    Muñoz JA; López-Mesas M; Valiente M
    Urology; 2012 Nov; 80(5):1163.e13-8. PubMed ID: 22748613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and physicochemical presentations of patients with brushite stones.
    Pak CY; Poindexter JR; Peterson RD; Heller HJ
    J Urol; 2004 Mar; 171(3):1046-9. PubMed ID: 14767267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of hydroxyapatite and pyrophosphate on the formation product of calcium oxalate at different pHs.
    Baumann JM; Ackermann D; Affolter B
    Urol Res; 1989; 17(3):153-5. PubMed ID: 2546312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the early stages of renal stone formation: experimental model using urothelium of pig urinary bladder.
    Grases F; García-Ferragut L; Costa-Bauzá A
    Urol Res; 1996; 24(5):305-11. PubMed ID: 8931296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.